BioNTech unveils a 'cheap' shipping-container kit for manufacturing vaccines globally
What do you get when you combine 12 shipping containers and some of the most innovative science surrounding vaccines there is?
A futuristic way to make in-demand vaccines.
BioNTech has made it known for months now that it wants to establish domestic manufacturing ops for vaccines in Africa, where access is a big issue and vaccination rates for Covid trail well behind affluent countries. And on Wednesday the company revealed its first “modular” mRNA manufacturing facilities in Senegal, Rwanda and “potentially South Africa.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.